| Ident. | Authors (with country if any) | Title |
|---|
| 000165 (2016) |
Michel Engeln [France] ; Matthieu F. Bastide [France] ; Estelle Toulmé [France] ; Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Christian E. Gross [France] ; Eric Boué-Grabot [France] ; Antonio Pisani [Italie] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France] | Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia. |
| 000253 (2016) |
Matthieu F. Bastide [France] ; Brice De La Crompe [France] ; Evelyne Doudnikoff [France] ; Pierre-Olivier Fernagut [France] ; Christian E. Gross [France] ; Nicolas Mallet [France] ; Thomas Boraud [France] ; Erwan Bézard [France] | Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia. |
| 000354 (2016) |
Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie] | Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. |
| 000373 (2016) |
N. Simon [France] ; F. Viallet [France] ; A. Boulamery [France] ; A. Eusebio [France] ; D. Gayraud [France] ; J-P Azulay [France] | A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients. |
| 000455 (2015) |
Maude Beaudoin-Gobert [France] ; Léon Tremblay [France] ; Véronique Sgambato-Faure [France] | [An implication of serotonergic fibers which goes beyond Levodopa-induced dyskinesia]. |
| 000457 (2015) |
Michel Engeln [France] ; Philippe De Deurwaerdère [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] ; Pierre-Olivier Fernagut [France] | Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia. |
| 000489 (2015) |
Marianne Amalric [France] | Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease. |
| 000543 (2015) |
Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni] | Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. |
| 000562 (2015) |
Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal] | New treatments for levodopa-induced motor complications. |
| 000622 (2015) |
Mariza Bortolanza [Brésil] ; Roberta Cavalcanti-Kiwiatkoski [Brésil] ; Fernando E. Padovan-Neto [Brésil] ; Célia Aparecida Da-Silva [Brésil] ; Miso Mitkovski [Allemagne] ; Rita Raisman-Vozari [France] ; Elaine Del-Bel [Brésil] | Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease. |
| 000651 (2015) |
C. Fidalgo [Italie] ; W K D. Ko [Royaume-Uni] ; E. Tronci [Italie] ; Q. Li [République populaire de Chine] ; R. Stancampiano [Italie] ; Q. Chuan [République populaire de Chine] ; E. Bezard [République populaire de Chine] ; M. Carta [Italie] | Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. |
| 000676 (2015) |
Erwan Bezard [France] ; Manolo Carta [Italie] | Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease? |
| 000808 (2014) |
Fabienne Ory-Magne [France] ; Jean-Christophe Corvol ; Jean-Philippe Azulay ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Philippe Damier ; Estelle Dellapina ; Alain Destée [France] ; Franck Durif ; Monique Galitzky ; Thibaud Lebouvier ; Wassilios Meissner ; Claire Thalamas ; François Tison ; Alexandrine Salis ; Agnès Sommet ; François Viallet ; Marie Vidailhet ; Olivier Rascol | Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. |
| 000815 (2014) |
Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada] | Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. |
| 000842 (2014) |
Serge Pinto [France] ; Murielle Ferraye [Pays-Bas] ; Robert Espesser [France] ; Valérie Fraix [France] ; Audrey Maillet [France] ; Jennifer Guirchoum [France] ; Deborah Layani-Zemour [France] ; Alain Ghio [France] ; Stéphan Chabardès [France] ; Pierre Pollak [Suisse] ; Bettina Debû [France] | Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility. |
| 000862 (2014) |
Wai Kin D. Ko [France] ; Marie-Laure Martin-Negrier [France] ; Erwan Bezard [France] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] | RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease. |
| 000938 (2014) |
Gregory Porras [France, Royaume-Uni] ; Philippe De Deurwaerdere [France] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Matteo Marti [Italie] ; Rudolf Morgenstern [Allemagne] ; Reinhard Sohr [Allemagne] ; Erwan Bezard [France, Royaume-Uni, République populaire de Chine] ; Michele Morari [Italie] ; Wassilios G. Meissner [France] | L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum |
| 000993 (2014) |
Wai Kin D. Ko [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [République populaire de Chine] | Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease. |
| 000A00 (2014) |
Martial Mermillod [France] ; Laurie Mondillon [France] ; Isabelle Rieu [France] ; Damien Devaux [France] ; Patrick Chambres [France] ; Catherine Auxiette [France] ; Hélène Dalens [France] ; Louise Marie Coulangeon [France] ; Isabelle Jalenques [France] ; Franck Durif [France] | Dopamine replacement therapy and deep brain stimulation of the subthalamic nuclei induce modulation of emotional processes at different spatial frequencies in Parkinson's disease. |
| 000A10 (2014) |
Gurdal Sahin [Suède] ; Lachlan H. Thompson [Suède, Australie] ; Sonia Lavisse ; Merve Ozgur [Suède] ; Latifa Rbah-Vidal ; Frédéric Dollé ; Philippe Hantraye ; Deniz Kirik [Suède] | Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease |
| 000A28 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
